This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
New research from ETH Zürich in Switzerland could see future wearable devices (with perhaps a few implants and a touch of geneticengineering) boost our health directly. Fitness trackers help you stay healthy by keeping count of your steps and monitoring your heart rate, driving you on to hit those cardio goals.
International research team including University of Göttingen explains advantages of molecular breeding methods Credit: M Qaim More than two billion people worldwide suffer from micronutrient malnutrition due to deficiencies in minerals and vitamins.
Combining discoveries in cancer immunology with sophisticated geneticengineering, Columbia University researchers have created a sort of "bacterial suicide squad" that targets tumors, attracting the host's own immune cells to the cancer to destroy it.
Geneticallyengineered products often require additional safety practices to ensure the infectious agents do not endanger participants, study staff, or the broader environment where such agents are administered. How can I protect myself from exposure? What should I do if I’m exposed?
Credit: McMaster University HAMILTON, ON June 28, 2021 — Researchers at McMaster University have developed a promising new cancer immunotherapy that uses cancer-killing cells geneticallyengineered outside the body to find and destroy malignant tumors.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Plant geneticengineering to fight hidden hunger.More than 2 billion people worldwide suffer from micronutrient malnutrition due to deficiencies in minerals and vitamins.
Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring an institutional biosafety committee (IBC) to provide additional oversight and risk assessment. IRBs are tasked with protecting research subject’s rights and welfare. What Does an IBC Review?
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Geneticallyengineered good bacteria could aid in combating disease.Our bodies are home to several bacterial species that help us maintain our health and wellbeing.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Geneticengineering without unwanted side effects helps fight parasites.Modified CRISPR-Cas9 gene editing scissors are enabling researchers at the University of Zurich to make alterations to the genetic … Continue reading (..)
A new study has found that a novel T cell geneticallyengineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.
Biomedical and geneticengineers at Duke University and the Albert Einstein College of Medicine have designed a small fluorescent protein that emits and absorbs light that penetrates deep into biological tissue.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Taking the guesswork out of geneticengineering: STAMPScreen pipeline helps streamline genetic studies in mammalian cell.Today’s geneticengineers have a plethora of resources at their disposal: an … Continue reading (..)
The use of engineeredgenetic materials in clinical trials is rapidly expanding, with potential applications for genetic vaccines, gene-modified cellular therapies, and gene therapies. A key part of the IBC’s evaluation is assessing the risks posed by the engineeredgenetic materials.
Researchers have solved a medical mystery in a poorly understood disease by uncovering which cells cause tumours in patients with tuberous sclerosis complex (TSC). As described in Cell Reports, they did this by creating geneticallyengineered kidney organoids, or “mini-kidneys” grown from human tissue.
Leveraging advancements in CRISPR-based geneticengineering, researchers at the University of California San Diego have created a new system that restrains populations of mosquitoes that infect millions each year with debilitating diseases.
To obtain human antibody responses within a mouse, mice are geneticallyengineered to be humanised for their Ig genes. KO-plus-transgenic humanisation involves generating geneticallyengineered (HumAb) mice by disrupting the endogenous mouse Ig genes and simultaneously introducing human Ig transgenes at a different and random location.
To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Pharmaceutical. Pfizer and Biogen stand in second and third positions, respectively.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: International research team argues for combination of organic farming and genetic engineering.For more sustainability on a global level, EU legislation should be changed to allow the use … Continue reading →
Treatment involving a single injection has long-lasting effects BOSTON – Researchers have used a geneticengineering strategy to dramatically reduce levels of tau–a key protein that accumulates and becomes tangled in the brain during the development of Alzheimer’s disease–in an animal model of the condition.
Credit: Avalos Lab/Princeton University Researchers at Princeton University have created a new and improved way to more precisely control geneticallyengineered bacteria: by simply switching the lights on and off. Working in E.
Scientists prove cell-cultured meat products can offer enhanced nutrition compared to conventionally produced meat A group of researchers at Tufts University have geneticallyengineered cow muscle cells to produce plant nutrients not natively found in beef cells.
Researchers develop tunable system that harnesses the spread of cargo carried by gene drives Credit: Gerard Terradas, UC San Diego Powerful new geneticengineering methods have given scientists the potential to revolutionize several sectors of global urgency.
Delytact (teserpaturev) is a geneticallyengineered oncolytic herpes simplex virus type 1 (HSV-1) that was approved for marketing in Japan earlier this year, and received pricing approval in August at 1.43 million yen (around $12,500) per dose, according to a Pharma Japan report.
First-of-its-kind advance holds promise for making new strides in research, treatments Irvine, Calif., April 27, 2021 — University of California, Irvine biologists have developed a new geneticallyengineered mouse model that, unlike its predecessors, is based on the most common form of Alzheimer’s disease.
As Nick Spittal states in this Advarra press release, membership in the Gene Therapy Ready (GTR) site network “allows Velocity to start studies over a month faster and provides a meaningful credential and important validation that increases sponsors’ confidence in our specialized capabilities to conduct complex clinical research safely.”
Gene therapy research is booming in the clinical setting. In this blog, we summarize the growth, risks, and regulatory requirements for gene therapy research. We also discuss how a centralized biosafety review process can benefit this type of research.
Innovation S-curve for the pharmaceutical industry Gene splicing using nucleases is a key innovation area in the pharmaceutical industry Nucleases play a fundamental role in the field of recombinant DNA technology, or geneticengineering. Nucleases are enzymes that hydrolytically cleave the phosphodiester backbone of DNA.
The NIH Guidelines also stipulate that at least two members of each IBC come from the surrounding community and be unaffiliated with the institution where the research is occurring apart from their membership on the IBC. Many of those original concerns of the 1970s and 1980s surrounding geneticengineering have lessened over time.
The US National Institutes of Health said that the research it had co-funded used AI to transform a bacterial protein into a new research tool. It was led by researchers in the lab of Dr Lin Tian, principal investigator at the University of California Davis School of Medicine.
According to studies conducted by researchers at Cincinnati Children’s Hospital, the bacteria can help heal damaged intestinal tissues. The study developed and researched microbe-controlled and genetically-engineered mice to understand the healing response in the intestine when receiving specific signals from bacteria.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Can a miniscule worm hold the secret to genetically reversing brain damage? A team of Hebrew University researchers have successfully used geneticengineering as a first step to … Continue reading →
Research in gene therapies and geneticallyengineered drugs and vaccines are growing exponentially, and will only continue to become more popular. This was just one of many questions we explore in our comprehensive survey of research sites and their internal activation practices. between 2020-2027.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged.Over the past decade, the CRISPR-Cas9 gene editing system has revolutionized geneticengineering, allowing … Continue (..)
Texas A&M AgriLife researchers’ work to aid mosquito control efforts To control mosquito populations and prevent them from transmitting diseases such as malaria, many researchers are pursuing strategies in mosquito geneticengineering.
-Geneticallyengineered therapy treats relapsed or refractory large B-cell lymphoma, a blood cancer- MILWAUKEE–(BUSINESS WIRE)–The CIBMTR® (Center for International Blood and Marrow Transplant Research®) today announced that it has reached a study enrollment goal 2 years early, and 1,500 patients … Continue reading → (..)
In the paper, researchers from Johns Hopkins University and elsewhere found a natural long-form transactivating CRISPR RNA (tracr-L) in Streptococcus pyogenes that functions to downregulate its endogenous CRISPR-Cas9 system. But altering the tracr-L with geneticengineering to make it function more like a guide RNA increased CRISPR-Cas9 cuts.
Originally released in 1976, the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules ( NIH Guidelines ) serve as the foundation of biosafety-focused oversight of research involving recombinant or synthetic nucleic acids (rsNA). Since then, however, certain geneticengineering technologies (e.g.,
The development of KRAS inhibitors is, thus, an extremely active line of research. As they state in the paper to be published in PNAS , “The biological relevance of the expression of two isoforms has puzzled researchers for decades.” ” Lung cancer and metastasis. ” KRAS genes in embryonic development.
Innovation S-curve for the pharmaceutical industry Zinc-finger nucleases is a key innovation area in pharmaceutical Zinc finger nucleases (ZFNs) are tools used in geneticengineering to cleave a chosen genomic sequence. While Intellia Therapeutics and Jackson ImmunoResearch Laboratories are in second and third positions, respectively.
Patients usually receive FVIII that comes from donor blood or is produced using geneticengineering. Researchers at the Paul-Ehrlich-Institut have found that complement proteins from the immune system strongly influence the reactions of T cells (immune cells) to FVIII and can be involved in inhibitor formation.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content